TMPRSS2:ERG Gene Fusion Might Predict Resistance to PARP Inhibitors in Metastatic Castration-resistant Prostate Cancer

Medicine and Dentistry

• Serine Proteinase 100%
• Gene Fusion 100%
• Castration Resistant Prostate Cancer 100%
• PARP Inhibitor 100%
• BRCA1 50%
• BRCA2 50%
• Treatment Duration 33%
• DNA Repair 33%
• Biological Marker 16%
• Prostate Cancer 16%
• Gene Mutation 16%
• Transcription Factors 16%
• Pharmacotherapy 16%
• Next Generation Sequencing 16%
• Molecularly Targeted Therapy 16%
• Homologous Recombination 16%

Biochemistry, Genetics and Molecular Biology

• Serine Protease 100%
• Gene Fusion 100%
• Poly ADP Ribose Polymerase 100%
• BRCA2 50%
• BRCA1 50%
• DNA Repair 33%
• Genetics 16%
• Gene Mutation 16%
• Transcription Factors 16%
• RNA 16%
• Next Generation Sequencing 16%
• Homologous Recombination 16%
• Genomics 16%

Keyphrases

• ERG Gene 100%
• PARPi Resistance 16%